Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1992 1
1996 1
1998 2
2004 1
2014 3
2017 5
2019 3
2020 6
2021 8
2022 7
2023 5
2024 7
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study.
Tani C, Cardelli C, Zen M, Moroni L, Piga M, Ceccarelli F, Fasano S, De Marchi G, Coladonato L, Emmi G, Gatto M, Trentin F, Ramirez GA, Chessa E, Gallina G, Picciariello L, Patrone M, Urban ML, Biancalana E, Quartuccio L, Ciccia F, Conti F, Cauli A, Dagna L, Doria A, Mosca M. Tani C, et al. Among authors: chessa e. J Rheumatol. 2024 Nov 1;51(11):1096-1101. doi: 10.3899/jrheum.2024-0053. J Rheumatol. 2024. PMID: 38950957
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development.
Floris A, Mugheddu C, Sichi L, Anedda J, Frau A, Sorgia J, Li Volsi L, Paladino MT, Congia M, Chessa E, Angioni MM, Naitza M, Ferreli C, Piga M, Atzori L, Cauli A. Floris A, et al. Among authors: chessa e. Rheumatology (Oxford). 2025 Mar 1;64(3):1131-1137. doi: 10.1093/rheumatology/keae257. Rheumatology (Oxford). 2025. PMID: 38781521
Targeted Therapies in Axial Psoriatic Arthritis.
Floris A, Congia M, Chessa E, Angioni MM, Piga M, Cauli A. Floris A, et al. Among authors: chessa e. Front Genet. 2021 Jun 28;12:689984. doi: 10.3389/fgene.2021.689984. eCollection 2021. Front Genet. 2021. PMID: 34262600 Free PMC article. Review.
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study.
Mattioli I, Gasparotto M, Bergamini A, Bortoluzzi A, Ciccia F, Conti F, D'agostino MA, Fredi M, Giacomelli R, Iannone F, Mormile I, Piga M, Quartuccio L, Sebastiani GD, Tani C, Vacca A, Zen M, Bettiol A, Emmi G; ESCULAPIO consortium. Mattioli I, et al. Eur J Intern Med. 2025 Jun 28:S0953-6205(25)00255-9. doi: 10.1016/j.ejim.2025.06.016. Online ahead of print. Eur J Intern Med. 2025. PMID: 40581512 Free article.
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus.
Cocco C, Manca E, Corda G, Angioni MM, Noli B, Congia M, Loy F, Isola M, Chessa E, Floris A, Lorefice L, Saba L, Mathieu A, Ferri GL, Cauli A, Piga M. Cocco C, et al. Among authors: chessa e. Front Immunol. 2023 Jun 13;14:1157149. doi: 10.3389/fimmu.2023.1157149. eCollection 2023. Front Immunol. 2023. PMID: 37383228 Free PMC article.
54 results